FDA backs Pfizer COVID-19 booster shots for people 65 and older, those at high risk

The FDA's decision came as CDC vaccine advisors wrapped up the first day of a two-day meeting on COVID-19 booster shots.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting